🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Second Duchenne patient dies after receiving Sarepta gene therapy biopharmadive.com/news/sarepta-e… $SRPT $RGNX $SLDB

FDA to miss approval deadline for Kalvista drug due to ‘resource constraints’ biopharmadive.com/news/kalvista-… $KALV

Sage, following Setbacks, to sell to Supernus for $561M biopharmadive.com/news/sage-ther… by Delilah Alvarado $SAGE $BIIB $SUPN

Roche, waving off study failures, commits to Phase 3 trials for Parkinson’s drug biopharmadive.com/news/roche-pro… Jon Gardner $PRTA + 11% $RHHBY $NVS $ABBV

Lilly to acquire Verve Therapeutics in $1B bet on gene editing for heart disease biopharmadive.com/news/lilly-acq… by Kristin Jensen $VERV $LLY

Scholar Rock drug preserves muscle in obesity trial biopharmadive.com/news/scholar-r… by Kristin Jensen $SRRK + 15% $REGN $BHVN $RHHBY $LLY

Draig, a brain drug startup, debuts with $140M to treat depression biopharmadive.com/news/draig-ser… by Gwendolyn Wu #biotech #startups $NBIX

FDA approves twice-yearly shot of Gilead drug for HIV prevention biopharmadive.com/news/gilead-fd… by Delilah Alvarado $GILD

A longer ‘winter’: Public funding slowdown heightens pressure on #biotech #startups biopharmadive.com/news/biotech-s… by Gwendolyn Wu

Gene therapy faces fresh uncertainty as two more top FDA officials depart biopharmadive.com/news/nicole-ve… #GeneTherapy

Compass’ big psychedelic study doesn’t impress investors biopharmadive.com/news/compass-p… by Jacob Bell $CMPS - 46% $GHRS $JNJ

Novo abruptly ends obesity drug deal with Hims biopharmadive.com/news/novo-hims… Jon Gardner $NVO $HIMS - 32%

Cidara stock soars as antiviral drug succeeds in flu study biopharmadive.com/news/cidara-st… by Delilah Alvarado $CDTX + 96%

Chasing rivals, Nuvalent to seek approval of targeted lung cancer drug biopharmadive.com/news/nuvalent-… $NUVL $NUVB $BMY $RHHBY

FDA investigating Elevidys safety; Nektar shares spike on eczema data biopharmadive.com/news/capricor-… $SRPT $NKTR $CAPR

RFK Jr's thimerosal thread is a masterclass in misinformation. Let's fact-check it line by line. 🧵

CDC panel, newly remade by RFK Jr., questions vaccine evidence biopharmadive.com/news/cdc-acip-… by Delilah Alvarado

Incyte replaces CEO Hoppenot with dealmaker Meury biopharmadive.com/news/incyte-ce… by Ned Pagliarulo $INCY $KRTX

Acadia’s ‘very bullish’ sales forecast restores some confidence on Wall Street biopharmadive.com/news/acadia-re… by Jacob Bell $ACAD

Vor, with new CEO, changes course to target autoimmune disease biopharmadive.com/news/vor-remeg… by Gwendolyn Wu $VOR